Abstract
Since the classical experiments of Otto Loewi, it has been known that acetylcholine acts as a neurotransmitter. The actions of acetylcholine are exerted on its receptors, and these receptors are subdivided according to pharmacological sensitivity to two alkaloids of natural origin—muscarine and nicotine. Although the effects of nicotine on the nervous system have been known for a number of years, research on nicotinic receptors focused mainly on the neuromuscular junction and in the neuro-neuronal synapsis in the autonomic ganglia. The actions of nicotine on the central nervous system (CNS) were largely ignored for years. In the last two decades, however, research on the effects of nicotine on the CNS has greatly increased. Recent results have revealed that there is a complex network of nicotine receptor subtypes, closely related to several neurotransmitter systems, that are able to regulate their function. This influence seems to be particularly important in the recently discovered reciprocal relationship between depression and the alterations of sleep often observed in this psychiatric disease. In this chapter we will review the current knowledge of the effects of nicotine and how it influences depression and concurrent sleep alterations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alkondon, M., Rocha, E. S., Maelicke, A., & Alburquerque, E. X. (1993) Diversity of nicotinic acetylcholine receptors in rat brain: V. Alpha-bungarotoxin-sensitive nicotinic receptors in olfactory bulb neurons and presynaptic modulation of glutamate release. Journal of Pharmacology and Experimental Therapeutics, 265, 1455–1473.
Aramakis, V. B., & Metherate, R. (1998). Nicotine selectively enhances NMDA receptor-mediated synaptic transmission during postnatal development in sensory neocortex. Journal of Neuroscience, 18, 8485–8495.
Ascher, P., Large, W. A., & Rang, H. P. (1979). Studies on the mechanism of action of acetylcholine antagonists on rat parasympathetic ganglion cells. Journal of Physiology, 295, 139–170.
Benca, R. M., Obermayer, W. H., Thisted, R. A., & Gillin, J. C. (1992). Sleep and psychiatric disorders; a meta-analysis. Archives of Genetic Psychiatry, 49, 651–668.
Borsini, F., & Meli, A. (1988) Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology, 94, 147–160.
Carr, D. B., & Sesack, S. R. (2000) Projections from the rat prefrontal cortex to the ventral tegmental area: Target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. Journal of Neuroscience, 20, 3864–3873.
Chávez-Noriega, L. E., Corona, J. H., Washburn, M. S., Urrutia, A., Elliot, K. J., & Johnson, E. C. (1997). Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha2 beta2, h alpha2-beta4, h alpha3-beta2, h alpha 3-beta 4, h alpha4-beta2, h alpha4-beta4 and h alpha7 expressed in xenopus oocytes. Journal of Pharmacology and Experimental Therapeutics, 280, 346.
Corrigall, W. A., & Coen, K. M. (1991). Selective dopamine antagonists reduce nicotine self-administration. Psychopharmacology, 104, 171–176.
Corrigall, W. A., Coen, K. M., & Adamson, K. L. (1994). Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Research, 653, 274–278.
Corringer, P. J., Le Novere, N., & Changeux, J. P. (2000). Nicotinic receptors at the amino acid level. Annual Review of Pharmacology and Toxicology, 40, 431–458.
Covey, L. S. (1999). Tobacco cessation among patients with depression. Primary Care, 26, 691–706.
Davila, D. G., Hurt, R. D., Offord, K. P., Harris, C. D., & Shepard, J. W., Jr. (1994). Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers. American Journal of Respiratory and Critical Care Medicine, 150, 469–474.
Delashaw, J. B., Foutz, A. S., Guilleminault, C., & Dement, W. C. (1979) Cholinergic mechanisms and narcolepsy in dogs. Experimental Neurology, 66, 745–757.
Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. (1995). American Psychiatric Association. Washington, DC.
DiChiara, G., & Imperato, A. (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proceedings of the National Academy of Science USA, 85, 5274–5278.
Djuríc, V. J., Dunn, E., Overstreet, D. H., Dragomir, A., & Steiner, M. (1999). Antidepressant effect of ingested nicotine in female rats of Flinders resistant and sensitive lines. Physiology Behavior, 67, 533–537.
Domino, E., & Yamamoto, K. (1965). Nicotine: Effect on the sleep cycle of the cat. Science, 150, 637–638.
Garzon, M., Vaughan, R. A., Uhl, G. R., Kuhar, M. J., & Pickel, V. M. (1999). Cholinergic axon terminals in the ventral tegmental area target a subpopulation of neurons expressing low levels of the dopamine transporter. Journal of Comparative and Neurology, 410, 197–210.
George, R., Haslett, E. L., & Jenden, D. J. (1964). A cholinergic mechanism in the brain stem reticular formation: Induction of paradoxical sleep. International Journal of Neuropharmacology, 3, 541–552.
Gilbert, D. G. (1979). Paradoxical tranquilizing and emotion-reducing effects of nicotine. Psychological Bulletin, 86, 643–661.
Giles, D. E., Jarret, R. B., Roffwarg, H. P., & Rush, A. J. (1987) Reduced rapid eye movement latency. A predictor of recurrence in depression. Neuropsychopharmacoogy, 1, 51–59.
Gillin, J. C., Lardon, M., Ruiz, C., & Golshan, S. (1994). Dose-dependent effects of transdermal nicotine on early morning awakening and rapid eye movement sleep time in nonsmoking normal volunteers. Journal of Psychopharmacology, 14, 264–267.
Gillin, J. C., Rapaport, M., Erman, M. K., Winocur, A., & Albala, B. J. (1997). A comparision of nefazodone and fluoxetine on mood and on objective, subjective, and clinician rated measures of sleep in depressed patients: A double-blind, 8-week clinical trial. Journal of Clinical and Psychiatry, 58, 185–192.
Glassman, A. H. (1993). Cigarette smoking: Implications for psychiatric illness. American Journal of Psychiatry, 150, 546–553.
Haro-Valencia, R., & Drucker-Colín, R. R. (2004). A two-year study on the effects of nicotine and its withdrawal on mood and sleep. Pharmacopsychiatry, 37, 221–227.
Hendrickse, W. A., Roffwarg, H. P., Grannemann, B. D., Orsulak, P. J., Armitage, R., Cain, J. W., Battaglia, J., Debus, J. R., & Rush, A. J. (1994). The effects of fluoxetine on the polysomnogram of depressed outpatients: A pilot study. Neuropsychopharmacology, 10, 85–91.
Hernández-Peón, R., Chavez-Ibarra, G., Morgane, P. J., & Timo-Iaria, C. (1963). Limbic cholinergic pathways involved in sleep and emotional behavior. Experimental Neurology, 8, 93–111.
Hill, J. A., Zoli, M., Burgeois, J. P., & Changeux, J. P. (1993). Immunocytochemical localization of a neuronal nicotinic receptor: The beta 2 subunit. Journal of Neuroscience, 13, 1551–1568.
Imperato, A., Mulas, A., & Di Chiara, G. (1986). Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. European Journal of Pharmacology, 132, 337–338.
Itier, V., & Bertrand, D. (2001). Neuronal nicotinic receptors: From protein structure to function. FEBS Letters, 504, 125–128.
Janowsky, D. S., El-Yousef, M. K., Davis, J. M., & Sekerke, H. J. (1972). A cholinergic-adrenergic hypothesis of mania and depression. Lancet, 2, 632–635.
Jewett, R. E., & Norton, S. (1986). Effect of some stimulant and depressant drugs on sleep cycles of cats. Experimental Neurology, 15, 463–474.
Kalivas, P. W., Churchill, L., & Klitenick, M. A. (1993). GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area. Neuroscience, 57, 1047–1060.
Kalivas, P. W., Duffy, P., & Barrow, J. (1989). Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. Journal of Pharmacology and Experimental Therapeutics, 251, 378–387.
Kalman, D. (2002). The subjective effects of nicotine: Methodological issues, a review of experimental studies, and recommendations for future research. Nicotine and Tobacco Research, 4, 25–70.
Ke, L., Eisenhow, C. M., Bencherif, M., & Lukas, R. J. (1998). Effects of chronic nicotine treatment on expression of diverse nicotinic acetylcholine receptor subtype: 1. Dose-and time-dependant effects of nicotine treatment Journal of Pharmacology and Experimental Therapeutics, 286, 825–840.
Killen, J. D., Fortmann, S. P., Schatzberg, A., Hayward, C., & Varady, A. (2003). Onset of major depression during treatment for nicotine dependence. Addictive Behaviors, 28, 461–470.
Klink, R., de Kerchove, D. A., Zoli, M., & Changeux, J. P. (2001). Molecular and physiological diversity of nicotine acetylcholine receptor in the midbrain dopaminergic nuclei. Journal of Neuroscience, 21, 1452–1463.
Lief, H. I. (1996). Bupropion treatment of depression to assist smoking cessation. American Journal of Psychiatry, 153(3), 442.
Louis, M., & Clarke, P. B. (1998). Effect of ventral tegmental 6-hydroxydopamine lesions on the locomotor stimulant action of nicotine in rats. Neuropharmacology, 37(12), 1503–1513.
Mansvelder, H. D., Keath, J. R., & McGehee, D. S. (2002). Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron, 33, 905–919.
Markou, A. Kosten, T. R., & Koob, G. F. (1998). Neurobiological similarities in depression and drug dependence: A self-medication hypothesis. Neuropsychopharmacology, 18, 135–174.
Martínez-González, D., Prospéro-García, O., Mihailescu, S., & Drucker-Colín, R. (2002). Effects of nicotine on alcohol intake in a rat model of depression. Pharmacology, Biochemistry and Behavior, 72, 355–364.
Mihailescu, S. & Drucker-Colín, R. R. (2000). Nicotine, brain nicotine receptors and neuropsychiatric disorders. Archives of Medical Research, 31, 131–144.
Mihailescu, S., Palomero-Rivero, M., Meade-Huerta, P., Maza-Flores, A., & Drucker-Colín, R. (1998). Effects of nicotine and mecamylamine on rat dorsal raphe neurons. European Journal of Pharmacology, 360, 31–36.
Moreno, A., Calderón, M. C., & Drucker-Colín, R. (2005). Long-term study of mood and sleep of chronic smokers during abstinence. Addiction (submitted).
Nisell, M., Nomikos, G. G., & Svensson, T. H. (1994). Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse, 16, 36–44.
Overstreet, D. H. (1986). Selective breeding for increased cholinergic function: Development of a new model of depression. Biology Psychiatry, 21, 49–58.
Picciotto, M. R., Solí, M., Rimondini, R., Lena, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J. P. (1998). Acetylcholine receptors containing the beta2 subunit are involved in reinforcing properties of nicotine. Nature, 391, 173–177.
Pidoplichco, V. I., DeBiasi, M., Williams, J. T., & Dani, J. A. (1997). Nicotine activates and desensitizes midbrain dopamine neurons. Nature, 390, 401–404.
Porsolt, R., Le Pichon, M., & Jalfre, M. (1977). Depression: A new animal model sensitive to antidepressant treatmenta. Nature, 266, 730–732.
Sacaan, A. I., Reid, R. T., Santori, E. M., Adams, P., Correa, L. D., Mahaffy, L. S., Bleicher, L., Oxford, N. D., Stauderman, K. A., McDonald, I. A., Rao, T. S., & Lloyd, G. K. (1997). Pharmacological characterization of SIB-1765F: A novel cholinergic ion channel agonist. Journal of Pharmacology and Experimental Therapeutics, 280, 373.
Salín-Pascual, R. J., De la Fuente, J. R., Galicia Polo, L., & Drucker-Colín, R. R. (1995). Effects of transdermal nicotine on mood and sleep in nonsmoking major depressed patients. Psychopharmacology, 121, 476–479.
Salín-Pascual, R. J., & Drucker-Colín, R. R. (1998). A novel effect of nicotine on mood and sleep in major depression. Neuroreport, 9, 57–60.
Salín-Pascual, R. J., Moro Lopez, M. L., González Sánchez, H., & Blanco Centurión, C. (1999). Changes in sleep after acute and repeated administration of nicotine in the rat. Psychopharmacology, 145, 133–138.
Semba, J., Mataki, C., Yamada, S., Nankai, M., & Toru, M. (1998). Antidepressant-like effects of chronic nicotine on learned helplessness paradigm in rats. Biology Psychiatry, 43, 389–391.
Tao, T. S., Correa, L. D., Adams, P., Santori, E. M., & Sacaan, A. I. (2003). Pharmacological characterization of dopamine, norepinephrine and serotonin in the rat prefrontal cortex by neuronal nicotinic acetylcholine receptor agonists. Brain Research, 990, 203–208.
Tsoh, J. Y., Humfleet, G. L., Munoz, R. F., Reus, V. I., Hartz, D. T., & Hall, S. M. (2000). Development of major depression after treatment for smoking cessation. American Journal of Psychiatry 157(3), 368–374.
Tzschentke, T. M. (2001). Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Progress in Neurobiology, 63(3), 241–320.
Umbriaco, D., Garcia, S., Beaulieu, C., & Descarries, L. (1995). Relational features of acetylcholine, noradrenaline, serotonion and GABA axon terminal in the striatum radiatum of adult rat hippocampus (CA1). Hippocampus, 5, 605–620.
Vázquez-Palacios, G., Bonilla-Jaime, H., & Velázquez-Moctezuma, J. (2004). Antidepressant-like effects of the acute and chronic administration of nicotine in the rat forced swimming test and its interaction with flouxetine. Pharmacology, Biochemistry and Behavior, 78, 165–169.
Vázquez-Palacios, G., Bonilla-Jaime, H., & Velázquez-Moctezuma, J. (2005). Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine. Progress in Neuropsychopharmacology and Biological Psychiatry, 29, 39–46.
Velázquez-Moctezuma, J., Shalauta, M. D., Gillin, J. C., & Shiromani, P. J. (1990) Microinjection of nicotine in the medial pontine reticular formation elicits REM sleep. Neuroscience Letters, 115, 265–268.
Velázquez-Moctezuma, J., Shiromani, P. J. & Gillin, J. C. (1990). Acetylcholine and acetylcholine receptor subtypes in REM sleep generation. Progress in Brain Research, 84, 407–413.
Vezina, P., Herve, D., Glowinski, J., & Tassin, J. P. (1994). Injections of 6-OHDA into the ventral tegmental area destroy mesocorticolimbic dopamine neurons but spare the locomotor activating effects of nicotine. Neuroscience Letters, 168, 11–114.
Vizi, E. S., & Kiss, J. P. (1998). Neurochemistry and pharmacology of the major hippocampal transmitter systems: Synaptic and nonsynaptic interactions. Hippocampus, 8, 566–607.
Vizi, E. S., & Labos, E. (1991). Nonsynaptic interactions at presynaptic level. Progress in Neurobiology, 37, 145–163.
Vizi, E. S., & Lendvai, B. (1999). Modulatory role of presynaptic nicotinic receptors in synaptic and nonsynaptic chemical communication in the central nervous system. Brain Research Reviews, 30, 219–235.
Vogel, G., Hartley, P., Neill, D., Hagler, M., & Kors, D. (1990). A new animal model of endogenous depression: A summary of present finding. Neuroscience Biobehavior Review, 14, 85–91.
Wada, E., Wada, K., Boulter, J., Deneris, E., Heinemann, S., Patrick, J., & Swanson, L. W. (1989). Distribution of alpha2, alpha3, alpha 4 and beta 2 nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the rat. Journal of Comparative Neurology, 284, 314.
Whiting, P., & Lindstrom, J. (1986). Pharmacological properties of immuno-isolated neuronal acetylcholine receptors. Journal of Neuroscience, 6, 3061.
Willner, P. (1991). Behavioral models in psychopharmacology. Cambridge, UK: Cambridge University Press.
Wonnacott, S. (1997). Presynaptic nicotinic Ach receptors. Trends in Neuroscience, 20, 92–98.
Yang, X., Criswell, H. E., & Breese, G. R. (1996). Nicotine-induced inhibition in medial septum involves activation of presynaptic nicotinic cholinergic receptors on gamma-aminobutyric acid-containing neurons. Journal of Pharmacology and Experimental Therapeutics, 276, 482–489.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Velázquez-Moctezuma, J., Drucker-Colín, R. (2006). Nicotine, Sleep, and Depression. In: Yehuda, S., Mostofsky, D.I. (eds) Nutrients, Stress, and Medical Disorders. Nutrition and Health. Humana Press. https://doi.org/10.1385/1-59259-952-4:231
Download citation
DOI: https://doi.org/10.1385/1-59259-952-4:231
Publisher Name: Humana Press
Print ISBN: 978-1-58829-432-6
Online ISBN: 978-1-59259-952-3
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)